ESG

Social

Human Rights Management Goals

Ligachem Bioscience recognizes that protecting the human rights of various stakeholders, including employees, and preventing human rights violations are essential conditions for sustainable management and growth.
Accordingly, the Company established the Human Rights Management Declaration and Human Rights Management Regulations, including the signature of the CEO, to prevent human rights violations and mitigate related risks while actively implementing human rights management.

Declaration of Human Rights Management

1, Through this Declaration of Human Rights Management, Ligachem Biosciences will do its best to identify, prevent, mitigate and cope with human rights risks that may arise throughout its management activities.

2, For the implementation of human rights management, we comply with international and domestic human rights norms such as the Universal Declaration of Human Rights, the International Bill of Rights, the United Nations guiding principles on business and human rights, the International Labor Organization, the Organization for Economic Cooperation (OECD Guidelines for Multinational Enterprises, and the United Nations Convention on the Rights of the Child.)

3, In accordance with the human rights policy statement, we will monitor human rights risks, correct them immediately, immediately remedy and support the damage caused by non-compliance, and report on progress. In addition, we promise to guide and actively cooperate with judicial or non-judicial remedies if they are not resolved through internal grievance and relief procedures.

4, We will apply stricter standards if the international human rights and standards set forth in this human rights policy statement conflict with the laws and regulations of the country in which each workplace is located. In addition, we will actively respond to and support human rights principles so as not to cause a negative impact on human rights or to be involved in or abetted human rights violations.

5, The application of this human rights policy includes all executives and employees of the company and its subsidiaries. In addition, the executives and employees of Ligachem Bio follow human rights policies when dealing with suppliers and stakeholders and encourage all stakeholders in business relationships to respect human rights policies.

6, All of our executives and employees will perform their duties in accordance with this human rights policy statement, except for special provisions in the articles of association or private affairs of a law or organization.

Roadmap for Human Rights Management

Ligachem Biosciences has established and implemented a roadmap for human rights management.
The company plans to conduct education to raise human rights awareness of its members by 2024 and prepare and operate a process to deal with human rights violations.

Roadmap for Human Rights Management

Phase 1
2024
- Conducting education to raise awareness of human rights
- Operation of Human Rights Violation Complaint Process
Phase 2
2025

Complete safety training 100%
Sexual harassment prevention education, disability awareness improvement education and workplace harassment prevention education
Conducting Human Rights Impact Assessment
Phase 3
2026
- Enhance the system of prevention and monitoring of human rights violations
- Preparation of improvement plan reflecting the human rights impact assessment results and continuous management of evaluation results

a grievance system

For cultivate human rights awareness for all employees of the company, we provide sexual harassment prevention, workplace awareness improvement, and workplace harassment prevention education every year.

Complaint handling executives and employees

Ligachem Biosciences operates "DooDream," a channel that allows you to report human rights-related grievances and reports on our website.

grievance procedures

Report
- in oral / written language
- Online (DooDream)
Listening/ Processing
- start without delay
- Listening to opinions
- a factual investigation
Notification of results
- Notification within 10 days
- Measures
- Processing results
Record Management
- Create Processing Log
- one-year retention obligation
- confidentiality/access control

external stakeholders

Ligachem Biosciences is receiving reports on acts that hinder ethical management and corruption that have caused unfair gains or losses related to external stakeholders such as partners.

Reporting method

Processing procedures

01
Receipt of report You can register through the website About US Ethics Management – DooDream - Report .
02
Check the report content After checking the contents, if necessary, additional facts related to the issue of the report will be checked.
03
Conducting an investigation Determine the subject, scope, and plan of the survey and conduct the survey accordingly
04
Investigation completed Complete the investigation by preparing and reporting incident reports after fact-checking and evidence.
05
The end. In accordance with the regulations, the respondent is given measures, training to prevent recurrence, and process improvement.

Increasing Diversity

Ligachem Biosciences Inc. seeks to establish and implement short-term goals to enhance the diversity of its executives and employees .
The company plans to continue its efforts to enhance the diversity of its employees and to secure a foundation for improving the company′s capabilities and leapfrogging.

Roadmap to Improve the Diversity of Employees

Phase 1
2024

Securing global R&D technology by hiring two or more foreign researchers
Phase 2
2025

More than 50% of female managers (team leaders, center heads)
Phase 3
2026

Securing female registered executives